The insulin resistance syndrome represents a metabolic state in which hyperinsulinemia and/or insulin resistance constitute the platform underlying the development of metabolic complications and related diseases such as diabetes and coronary heart disease. As described in this paper, these insulin-related changes are also involved in the regulation of energy balance and contribute to the recovery of body weight stability in a context of long-term positive energy balance. Under conditions of negative energy balance such as obesity treatment, this connection has a high clinical relevance. In this regard, relevant literature as well as the reanalysis of previously published data suggest that the beneficial effect of weight loss on insulin-related changes in glycemia cannot be disassociated from the relationship between changes in plasma insulin and those in resting energy expenditure. In clinical terms, this suggests that the beneficial effect of weight loss on components of the insulin resistance syndrome could be related to the development of a state of physiological vulnerability that complicates the control of body weight. This poses a major challenge to health professionals who then have to manage obesity treatment as the search for a compromise between the beneficial and potentially detrimental effects of weight loss on insulinemia and insulin sensitivity. This also reinforces the relevance to adhere to healthy diet and physical activity habits in order to maintain body weight stability rather than relying on the overuse of regulatory systems soliciting the effects of hyperinsulinemia on the control of energy intake and expenditure.
Introduction
Insulin is well known to influence macronutrient and energy metabolism via diverse mechanisms. In the periphery, it promotes substrate uptake, inhibits substrate mobilization, and favors glycogen, protein, and lipid synthesis. It also indirectly influences the distribution of energy substrates by affecting vascular physiology. At the level of the brain, it is involved in the regulation of macronutrient balance via its effects on the neurobiological control of food intake and of substrate oxidation. Insulin thus appears as a major 'manager' of metabolism for which its anabolic and catabolic effects are coordinated to promote blood substrate clearance.
Traditionally, insulin sensitivity was primarily considered with regard to its ability to promote peripheral glucose uptake, and this in turn has been used by diabetologists as an indication of the risk to develop diabetes. In 1988, Reaven 1 broadened the perception of the clinical impact of insulin sensitivity by proposing the concept of Syndrome X that has also been described as the insulin resistance syndrome or the metabolic syndrome. According to this concept, insulin is considered to exert a pivotal role in the development of metabolic complications such as hyperglycemia, dyslipidemia and hypertension. As indicated above, the ability of insulin to promote glucose and lipid uptake as well as glycogenesis and lipogenesis, and to favor vascular dilatation, is compatible with this concept and extends the clinical notion of insulin sensitivity.
The insulin resistance syndrome is of particular interest in the field of obesity since excess body fat accumulation, and especially visceral fat deposition, is a factor that promotes substantial detrimental effects on the components of the syndrome. 2 For health professionals such as physicians and nutritionists, the corollary is relatively obvious and emphasizes the importance of treating obesity to attenuate the burden of related metabolic complications and to prevent their long-term consequences such as diabetes mellitus and coronary heart disease. However, clinical and experimental evidence reveals that obesity management as a strategy to treat the insulin resistance syndrome also yields some less desirable effects, which pertain to the impact of insulin on the regulation of energy balance. In this regard, the main goal of this paper is to discuss the possibility that Syndrome X might be the unfortunate price to be paid as the body strives for weight stability in a context favoring a positive energy balance.
Insulinostatic theory of appetite control
Insulin behaves like an anorectic and thermogenic agent when glycemia remains stable. This was initially demonstrated in baboons which displayed a decrease in food intake and body weight in response to insulin administration in the brain under conditions of euglycemia. 3 This observation represents a key argument of an insulinostatic theory of appetite control that was proposed by Woods and Porte 4 and
Porte and Woods 5 more than 20 years ago and for which there is now considerable compelling evidence. [6] [7] [8] This concept reveals a different role of the involvement of insulin in the regulation of energy balance and is concordant with the documented enhancing effect of insulin on sympathetic nervous system activity (SNS) during a euglycemic-hyperinsulinemic clamp test. [9] [10] [11] The insulinostatic theory is also consistent with the reducing effect of insulin on the gene expression of neuropeptide Y (NPY), 12 a neuropeptide for which the orexigenic effects are well established, and with the stimulating effect of insulin on proopiomelanocortin (POMC), 13 which is the precursor molecule for the anorexigenic neuropeptide a-melanocye stimulating hormone (aMSH). The synergy that insulin exerts with leptin, 14, 15 which also stimulates SNS activity, reduces NPY levels, 16 and exerts a catabolic action through POMC/aMSH. 17 In addition, insulin stimulates leptin mRNA expression 18 and has been shown to increase leptin levels even in physiological amounts. 19 These observaitons are in agreement with a regulatory role of insulin on energy balance via the brain. Human studies also support the existence of a role for insulin in the attenuation of weight gain in a context of positive energy balance. For instance, in the long-term Quebec overfeeding study, the subjects with the largest increase in postprandial insulinemia following the excess energy intake protocol exhibited a significantly greater increase in energy expenditure compared to those whose insulinemia remained stable. 20 It is noteworthy to emphasize that this difference was observed under conditions of stable glycemia in each group and was independent of variations in fat-free mass. This is concordant with data obtained in Pima Indians where the initial state of both insulin resistance 21 and elevated insulin secretion 22 predicted reduced weight gain over several years of follow-up.
In summary, the insulinostatic theory of appetite control provides a rationale which suggests that an increase in insulin facilitates the recovery of body weight stability under conditions of long-term positive energy balance. This in turn raises the possibility that in the context of a weight-reducing program, the decrease in plasma insulin could be a source of vulnerability for body weight regain in the reduced obese state.
Is the metabolic syndrome the price to be paid to achieve body weight stability?
The answer to this question requires the consideration of two conceptual entities that have generally been considered separately. On the one hand, there is a clinical paradigm which describes insulin resistance as a common platform for the development of various complications, which ultimately lead to diseases such as diabetes and coronary heart disease. On the other hand, a physiological perception emphasizes the role of insulin as a key player in the central regulation of energy balance. Understanding the totality of these effects can most easily be understood with an integration of the systemic anabolic impact of insulin with its central catabolic action; for example, the stimulation of energy metabolism probably via an increase in SNS activity. As discussed above, these effects contribute to the achievement of a homeostatic state, be it in the context of excess food intake or under conditions of food deprivation.
Tremblay and Doucet 23 recently described a certain number of adaptations that make the maintenance of body weight stability in a reduced obese state more difficult. These include an increase in hunger and desire to eat, and a greater than predicted decrease in energy expenditure, be it in the resting state or during exercise. Changes in these phenotypes are potentially related to changes in insulin. However, the extent to which there are consistent changes between Syndrome X-related variables, energy metabolism, and insulinemia remains an issue that has not been specifically considered.
As a first attempt to document this relationship, we reanalyze the data of a study for which results have already been partly published. 24 Briefly, obese men and women were subjected to a 15-week weight loss program, during which relevant parameters were measured before, after 2 and 8 weeks of protocol, and at the end of the study. For the purpose of the present analysis, we used resting energy expenditure (REE) and fasting plasma glucose and insulin over the first 2 weeks of treatment since this represents a period during which a substantial energy deficit can be tolerated without having to deal with the confounding effects of large body weight/fat changes.
The results of the correlational analyses among the changes in these variables over the first 2 weeks of the intervention are presented in Figure 1 . Over the course of the first 2 weeks, body weight had been reduced by Figure 1 indicates that there was a significant positive correlation between changes in fasting plasma insulin and glucose, which is concordant with the idea that the large decrease in insulin likely reflected a concomitant improvement in insulin sensitivity. Figure 1 also indicates that the relationship between changes in plasma insulin and those in REE was also positive and of the same order. This association implies that the greater the decrease in insulinemia, the greater the decrease in REE, after adjustment for relevant confounding variables. Since a lower than predicted energy expenditure is a marker of the likelihood to gain body weight over time 25 and that weight loss-induced changes in REE are predictive of weight regain, 26 the insulin-related decrease in REE likely represents an adaptation complicating the long-term maintenance of body weight stability at a reduced level. These findings support the hypothesis that insulin resistance is an adaptation for weight maintenance. 27 For health professionals, the results presented in this figure pose an important challenge to improve the metabolic profile of their patients without promoting vulnerability towards the control of body weight. In this regard, our results are disappointing since they indicate that early in a weight-reducing program, these two phenomena cannot be dissociated. In other words, the reduced obese person might experience more difficulty in maintaining body weight stability because of an improved metabolic status. Conversely, under conditions of positive energy balance, it is likely that the metabolic syndrome might be the price to be paid to achieve body weight stability.
Conclusion
The rationale and data reanalysis presented in this paper show that insulin sensitivity and its related variations in insulinemia not only represent a risk factor for metabolic diseases but also play a key role in the regulation of energy balance. In the context of overfeeding, the development of a state of insulin resistance/hyperinsulinemia promotes the occurrence of the metabolic syndrome but also favors over time the re-equilibration of energy intake and expenditure. Conversely, the decrease in insulinemia resulting from weight loss is accompanied by an improvement of metabolic health and also induces changes in appetite control and thermogenesis in a way that makes more difficult the longterm maintenance of a reduced body weight. For health professionals, these observations imply that body weight management should be performed with the preoccupation to maintain a reasonable balance between the health benefits of weight loss and its potential inconvenience on the control of energy intake and expenditure. In addition, the evidence presented in this paper reinforces the relevance of obesity prevention which should be the outcome of good practices in physical activity and diet since they promote the same effects as insulin on appetite control and thermogenesis, but without the detrimental effects of hyperinsulinemia on metabolic health. Insulin resistance and body weight stability A Tremblay et al
